Thursday - April 09, 2026

Multiple System Atrophy Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Neuramedy, ProMIS Neurosciences, Enterin Inc., Nippon Chemiphar

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple System Atrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Multiple System Atrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading

TECHSPO Dubai 2026 Unites Business, Tech and Marketing Leaders for High-Impact Expo

Dubai, UAE – TECHSPO Dubai Technology Expo returns September 22-23, 2026, to the Sofitel Dubai Jumeirah Beach Hotel, uniting business leaders, technologists, marketers, and innovators for a high-impact, two-day showcase of next-generation digital technology. Part of the globally recognized TECHSPO … Continue reading

DigiMarCon Silicon Valley 2026 Returns to San Francisco, Bringing the Future of Digital Marketing to the Global Stage

San Francisco, CA – DigiMarCon Silicon Valley, the premier digital marketing, media, advertising, and business conference and exhibition in the CA, will return June 16-17, 2026, at the Grand Hyatt San Francisco Hotel in San Francisco, CA. The three-day event … Continue reading

Non Tuberculous Mycobacterial Infections Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Insmed, AN2 Therapeutics, Mannkind Corp., Spero Therapeutics, Savara Pharmaceuticals

The Key Non- Tuberculous Mycobacterial Infections Companies in the market include – Insmed, AN2 Therapeutics, Mannkind Corporation, Spero Therapeutics, Savara Pharmaceuticals, Mallinckrodt Inc., Paratek Pharmaceuticals Inc., Revimmune, and others .   The Non- Tuberculous Mycobacterial Infections market is expected to … Continue reading

Hypertrophic Cardiomyopathy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Tenaya Therapeutics, Shandong Suncadia Medicine, MyoKardia

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Hypertrophic Cardiomyopathy pipeline constitutes 10+ key companies continuously working towards developing 10+ Hypertrophic Cardiomyopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading

Lewy Body Dementia Market: Accelerating Growth and Pipeline Impact by 2034– DelveInsight | Cognition Therapeutics, KeifeRx, Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics

The Key Lewy Body Dementia Companies in the market include – KeifeRx, Eisai, EIP Pharma, Sun Pharma, Axovant Sciences Ltd., Cognition Therapeutics, Cephalon, Athira Pharma, Ortho-McNeil Neurologics, Inc., H. Lundbeck A/S, Axovant Sciences Ltd., GE Healthcare, Aptinyx, NeuroActiva, Inc., CuraSen … Continue reading